The genetic determinants of the CYP3A5 polymorphism

Pharmacogenetics

Volumn 11, Issue 9, 2001, Pages 773-779

  Hustert, E ^a   Haberl, M ^a   Burk, O ^a   Wolbold, R ^a   He, Y Q ^a   Klein, K ^a   Nuessler, A C ^a   Neuhaus, P ^a   Klattig, J ^a   Eiselt, R ^a   Koch, I ^a   Zibat, A ^a   Brockmoller J ^a   Halpert, J R ^a   Zanger, U M ^a   Wojnowski, L ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

CYP3A4; CYP3A5; Drug metabolism; Polymorphism

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 3A5; LIVER ENZYME;

ARTICLE; CAUCASIAN; DRUG METABOLISM; ENZYME POLYMORPHISM; FRAMESHIFT MUTATION; HUMAN; LIVER; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RACE DIFFERENCE;

ALTERNATIVE SPLICING; BLOTTING, WESTERN; CYTOCHROME P-450 ENZYME SYSTEM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE FREQUENCY; GENETIC MARKERS; GERMANY; HUMANS; ISOENZYMES; MICROSOMES, LIVER; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SWITZERLAND; TRANSCRIPTION, GENETIC;

EID: 0035217180     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200112000-00005     Document Type: Article

References (26)

1. In vitro and in vivo drug interactions involving human CYP3A
2. Pharmacogenomics: Translating functional genomics into rational therapeutics
3. Substrates of human hepatic cytochrome P450 3A4
4. Expression of cytochrome P450 3A5 in Escherichia coli: Effects of 5′ modification, purification, spectral characterization, reconstitution conditions, and catalytic activities
5. In vivo activation of aflatoxin B1 in C57BL/6N mice carrying a human fetus-specific CYP3A7 gene
6. Structure-function relationships of human liver cytochromes P450 3A: Aflatoxin B1 metabolism as a probe
7. Policy forum: Public health. Reducing liver cancer - Global control of aflatoxin
8. cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450
9. Genomic organization of the human CYP3A locus: Identification of a new, inducible CYP3A gene
10. Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43
11. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine
12. Dissecting the function of cytochrome P450
13. Detection of CYP3A5 allelic variant: A candidate for the polymorphic expression of the protein?
14. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
15. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver
16. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3)
17. Identification of a cytochrome P450 in human fetal liver related to glucocorticoid-inducible cytochrome P450HLp in the adult
18. Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and the effect on substrate oxidation and cooperativity
19. Absence of hepatic cytochrome P450bufl causes genetically deficient debrisoquine oxidation in man
20. Characterization of a phenobarbital-inducible dog liver cytochrome P450 structurally related to rat and human enzymes of the P450IIIA (steroid-inducible) gene subfamily
21. Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues
22. Evidence for functional and structural multiplicity of pregnenolone-16 alpha-carbonitrile-inducible cytochrome P450 isozymes in rat liver microsomes
23. Sequence of the 5′-flanking region of CYP3A5: Comparative analysis with CYP3A4 and CYP3A7
24. Recommendations for a nomenclature system for human gene mutations
25. Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans
26. In vitro metabolism of quinidine: The (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes